KRTAP20-3: A Potential Drug Target and Biomarker (G337985)

Target Name: KRTAP20-3

NCBI ID: G337985

KRTAP20-3

KRTAP20-3: A Potential Drug Target and Biomarker

Keratin associated protein 19 (KRTAP20) is a cytoplasmic protein that plays a critical role in the regulation of cell growth, differentiation, and survival. The KRTAP20 gene has four exons, but only one gene product. Despite its small size, KRTAP20 has been shown to have numerous functions in various cellular processes, including cell adhesion, migration, and survival.

The discovery and characterization of KRTAP20 is a story of determination and innovation. Researchers have identified a unique protein that is expressed in high levels in various tissues and cells, but is highly conserved across species. The protein is composed of 214 amino acid residues and has a calculated molecular weight of 21.3 kDa.

KRTAP20 is highly expressed in various tissues, including brain, heart, liver, and muscle. It is also expressed in cell lines and human embryonic stem cells. KRTAP20 has been shown to play a role in several cellular processes, including cell adhesion, migration, and survival.

One of the most significant functions of KRTAP20 is its role in cell adhesion. KRTAP20 is involved in the formation of tight junctions, which are essential for maintaining tissue structure and function. KRTAP20 has been shown to be a critical component of tight junctions, as it is involved in the formation of these structures in various tissues.

In addition to its role in cell adhesion, KRTAP20 has also been shown to play a critical role in cell survival. KRTAP20 has been shown to promote the growth and survival of various cell types, including cancer cells. KRTAP20 has also been shown to play a role in the regulation of cell apoptosis, as it has been shown to induce cell death in various cell types.

The potential drug targets for KRTAP20 are vast and varied. One of the most promising targets is the inhibition of KRTAP20, as it has been shown to have a negative impact on the growth and survival of various cell types. The inhibition of KRTAP20 has been shown to result in the inhibition of cell adhesion, migration, and survival.

Another potential drug target for KRTAP20 is the stimulation of KRTAP20, as it has been shown to have a positive impact on the growth and survival of various cell types. The stimulation of KRTAP20 has been shown to result in the stimulation of cell adhesion, migration, and survival.

In conclusion, KRTAP20 is a unique and highly conserved protein that plays a critical role in various cellular processes. Its functions as a cell adhesion protein and its potential as a drug target make it an attractive target for further research and development.

Protein Name: Keratin Associated Protein 20-3

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP20-3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP20-3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets